Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine.

Yftach GepnerMerav MofazShay OvedMatan YechezkelKeren ConstantiniNir GoldsteinArik EisenkraftErez Shmueli Dan Yamin

Published in: Communications medicine (2022)

the considerably higher sensitivity of wearable sensors can revolutionize clinical trials by enabling earlier identification of abnormal reactions with fewer subjects.

Keyphrases

clinical trial
low cost
coronavirus disease
heart rate
sars cov
binding protein
phase ii
randomized controlled trial
bioinformatics analysis
living cells